|
|
|
|
|
Glucagon Acetate |
|
C153H225N43O49S |
|
16941-32-5 |
|
It is clinically used for the serious hypoglycemia reaction of diabetics under the treatment of insulin, the inhibition of gastrointestinal motility during gastrointestinal examination and the evaluation of maximum secretion of insulin ¥â cell of diabetics. |
|
Parameters of Product: 1 .Appearance :White powder 2 .Specific Optical Rotation (c=1,H2O) :-50.0~-60.0¡Æ 3 .Water Content(Karl Fischer) :¡Â10.0% 4 .Acetate Content(by HPLC) :¡Â15.0% 5 .Amino Acid Composition :¡¾10% of theoretical 6 .Purity (by HPLC) :¡Ã98.0% 7 .Single Impurity(by HPLC) :¡Â1.0% 8 .Peptide Content(by %N) :¡Ã80% 9 .Assay(By Anhydrous, Acetic Acid-free ) :95.0~105.0% 10 .Bacterial Endotoxins :¡Â5EU/mg
|
Industrial field |
pharmaceutical |
|
|
|
|
|
|
|
There are no existing companies to distribute selected chemical product |
|
|
|
|
|